Van beleggers
voor beleggers
desktop iconMarkt Monitor

Ontvang nu dagelijks onze kooptips!

word abonnee

Genmab, de Deense parel

3.284 Posts
Pagina: «« 1 ... 155 156 157 158 159 ... 165 »» | Laatste | Omlaag ↓
  1. Pokerface 5 november 2021 15:17
    PB:

    Genmab Improves its 2021 Financial Guidance
    Company Announcement

    Genmab improves its 2021 financial guidance

    COPENHAGEN, Denmark; November 4, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that it is improving its 2021 financial guidance published on August 11, 2021. The improved guidance is driven primarily by increased royalty revenue related to the net sales of DARZALEX® (daratumumab), both intravenous and subcutaneous formulations, and lower operating expense resulting from timing of investments for R&D activities and organizational capability build.

    Genmab’s projected revenue for 2021 primarily consists of DARZALEX royalties. Such royalties are based on Genmab’s revised estimate of DARZALEX 2021 net sales of USD 5.9–6.2 billion compared to Genmab’s previous estimate of USD 5.6-5.9 billion.


    Revised Previous
    (DKK million) Guidance Guidance
    Revenue 7,900 - 8,500 7,300 - 7,900
    Operating expenses (5,300) - (5,600) (5,500) - (5,800)
    Operating result 2,300 - 3,200 1,500 - 2,400

    Genmab’s financial results for the first nine months of 2021 will be published on November 10, 2021.

    The above expectations are based on assumptions including those described on pages 5 and 6 of the Interim Report for the First Half of 2021 (Company Announcement No. 60 / 2021).
  2. catch22 12 november 2021 20:09
    De voorgenomen splitsing vandaag aangekondigd door J&J in twee beursgenoteerde bedrijven.
    Kortom in medicijnen en related products , schept de verwachting om via jansen en jansen
    een bieding te doen op Genmab, hun grootste asset leverancier qua producten in de nabije toekomst.
    Eens of oneens .kom op met discussie. Forumleden Genmab
3.284 Posts
Pagina: «« 1 ... 155 156 157 158 159 ... 165 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

Indices

AEX 719,52 -0,87%
EUR/USD 1,0036 -0,53%
FTSE 100 7.550,37 +0,11%
Germany40^ 13.540,10 -1,15%
Gold spot 1.747,47 0,00%
NY-Nasdaq Composite 12.705,22 -2,01%

Stijgers

JUST E...
+25,75%
B&S Gr...
+2,18%
Avantium
+1,69%
UNILEV...
+1,04%
Pharming
+0,70%

Dalers

ADYEN NV
-7,01%
Aperam
-5,88%
Basic-Fit
-5,14%
Air Fr...
-5,05%
Arcelo...
-4,93%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links